Back to Search
Start Over
The Mifepristone Case and the Legitimacy of the FDA.
- Source :
-
JAMA: Journal of the American Medical Association . 6/27/2023, Vol. 329 Issue 24, p2121-2122. 2p. - Publication Year :
- 2023
-
Abstract
- This Viewpoint discusses a recent federal court decision that invaliated the Food and Drug Administration's (FDA) approval of mifepristone, a drug used to end pregnancies and manage miscarriage when used with misoprostol, and how that decision challenges the legitimacy and independence of the FDA. [ABSTRACT FROM AUTHOR]
- Subjects :
- *MIFEPRISTONE
*FEDERAL court decisions
*MISOPROSTOL
*MISCARRIAGE
*DRUG utilization
Subjects
Details
- Language :
- English
- ISSN :
- 00987484
- Volume :
- 329
- Issue :
- 24
- Database :
- Academic Search Index
- Journal :
- JAMA: Journal of the American Medical Association
- Publication Type :
- Academic Journal
- Accession number :
- 164662586
- Full Text :
- https://doi.org/10.1001/jama.2023.8712